INTELLIGENT BIO SOLUTIONS INC. Investment Income, Interest
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Investment Income, Interest of $110.33 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. investment income, interest for the quarter ending 2026-06-30 was $47.05K, a 419.40% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. investment income, interest for the quarter ending 2026-03-31 was $49.44K, a 179.55% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. investment income, interest for the quarter ending 2025-12-31 was $5.33K, a 75.68% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. investment income, interest for the quarter ending 2025-09-30 was $8.50K, a 83.91% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. investment income, interest for fiscal 2026 was $110.33K, a 8.67% increase from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. investment income, interest for fiscal 2025 was $101.52K, a 19.69% increase from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. investment income, interest for fiscal 2024 was $84.82K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $96.49K derived: sum of 2 quarters · filed 2026-08-19 | $101.83K derived: sum of 3 quarters · filed 2026-08-19 | $110.33K 10-K · filed 2026-08-19 |
| 2026-03-31 | $49.44K 10-Q · filed 2026-05-13 | $54.78K derived: sum of 2 quarters · filed 2026-05-13 | $63.28K 10-Q · filed 2026-05-13 | $72.34K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $5.33K 10-Q · filed 2026-02-12 | $13.84K 10-Q · filed 2026-02-12 | $22.90K derived: sum of 3 quarters · filed 2026-08-19 | $40.58K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $8.50K 10-Q · filed 2025-11-12 | $17.56K derived: sum of 2 quarters · filed 2026-08-19 | $35.25K derived: sum of 3 quarters · filed 2026-08-19 | $57.19K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $9.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $26.75K derived: sum of 2 quarters · filed 2026-08-19 | $48.68K derived: sum of 3 quarters · filed 2026-08-19 | $101.52K 10-K · filed 2026-08-19 |
| 2025-03-31 | $17.69K 10-Q · filed 2026-05-13 | $39.62K derived: sum of 2 quarters · filed 2026-05-13 | $92.46K 10-Q · filed 2026-05-13 | $163.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $21.94K 10-Q · filed 2026-02-12 | $74.78K 10-Q · filed 2026-02-12 | $145.31K derived: sum of 3 quarters · filed 2026-02-12 | $155.95K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $52.84K 10-Q · filed 2025-11-12 | $123.37K derived: sum of 2 quarters · filed 2025-11-12 | $134.01K derived: sum of 3 quarters · filed 2025-11-12 | $137.52K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $70.53K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $81.17K derived: sum of 2 quarters · filed 2025-08-15 | $84.68K derived: sum of 3 quarters · filed 2025-08-15 | $84.82K 10-K · filed 2025-08-15 |
| 2024-03-31 | $10.64K 10-Q · filed 2025-05-13 | $14.15K derived: sum of 2 quarters · filed 2025-05-13 | $14.29K 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $3.51K 10-Q · filed 2025-02-13 | $3.65K 10-Q · filed 2025-02-13 | ||
| 2023-09-30 | $139.00 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |